These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29183403)

  • 1. Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience.
    Ridge PG; Karch CM; Hsu S; Arano I; Teerlink CC; Ebbert MTW; Gonzalez Murcia JD; Farnham JM; Damato AR; Allen M; Wang X; Harari O; Fernandez VM; Guerreiro R; Bras J; Hardy J; Munger R; Norton M; Sassi C; Singleton A; Younkin SG; Dickson DW; Golde TE; Price ND; Ertekin-Taner N; Cruchaga C; Goate AM; Corcoran C; Tschanz J; Cannon-Albright LA; Kauwe JSK;
    Genome Med; 2017 Nov; 9(1):100. PubMed ID: 29183403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAB10: an Alzheimer's disease resilience locus and potential drug target.
    Tavana JP; Rosene M; Jensen NO; Ridge PG; Kauwe JS; Karch CM
    Clin Interv Aging; 2019; 14():73-79. PubMed ID: 30643396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.
    Guo X; Qiu W; Garcia-Milian R; Lin X; Zhang Y; Cao Y; Tan Y; Wang Z; Shi J; Wang J; Liu D; Song L; Xu Y; Wang X; Liu N; Sun T; Zheng J; Luo J; Zhang H; Xu J; Kang L; Ma C; Wang K; Luo X
    J Neural Transm (Vienna); 2017 Nov; 124(11):1455-1471. PubMed ID: 28770390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of lipid metabolism gene SAR1 homolog B and the risk of Alzheimer's disease and vascular dementia.
    Chen JH; Hsieh CJ; Huang YL; Chen YC; Chen TF; Sun Y; Wen LL; Yip PK; Chu YM
    J Formos Med Assoc; 2016 Jan; 115(1):38-44. PubMed ID: 25703997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A loss of function variant in CASP7 protects against Alzheimer's disease in homozygous APOE ε4 allele carriers.
    Ayers KL; Mirshahi UL; Wardeh AH; Murray MF; Hao K; Glicksberg BS; Li S; Carey DJ; Chen R
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):445. PubMed ID: 27358062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
    Yan T; Wang L; Gao J; Siedlak SL; Huntley ML; Termsarasab P; Perry G; Chen SG; Wang X
    J Alzheimers Dis; 2018; 63(1):157-165. PubMed ID: 29562525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer's disease.
    Miller JE; Shivakumar MK; Lee Y; Han S; Horgousluoglu E; Risacher SL; Saykin AJ; Nho K; Kim D;
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):76. PubMed ID: 30255815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.
    Amber S; Zahid S
    Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels.
    Maxwell TJ; Corcoran C; Del-Aguila JL; Budde JP; Deming Y; Cruchaga C; Goate AM; Kauwe JSK;
    Alzheimers Res Ther; 2018 Aug; 10(1):86. PubMed ID: 30153862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel age-informed approach for genetic association analysis in Alzheimer's disease.
    Le Guen Y; Belloy ME; Napolioni V; Eger SJ; Kennedy G; Tao R; He Z; Greicius MD;
    Alzheimers Res Ther; 2021 Apr; 13(1):72. PubMed ID: 33794991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing data.
    Saad M; Brkanac Z; Wijsman EM
    Genes Brain Behav; 2015 Nov; 14(8):607-17. PubMed ID: 26394601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
    Jiang S; Yang W; Qiu Y; Chen HZ;
    Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective genes and pathways in Alzheimer's disease: moving towards precision interventions.
    Seto M; Weiner RL; Dumitrescu L; Hohman TJ
    Mol Neurodegener; 2021 Apr; 16(1):29. PubMed ID: 33926499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.
    Ertekin-Taner N; Ronald J; Feuk L; Prince J; Tucker M; Younkin L; Hella M; Jain S; Hackett A; Scanlin L; Kelly J; Kihiko-Ehman M; Neltner M; Hersh L; Kindy M; Markesbery W; Hutton M; de Andrade M; Petersen RC; Graff-Radford N; Estus S; Brookes AJ; Younkin SG
    Hum Mol Genet; 2005 Feb; 14(3):447-60. PubMed ID: 15615772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCA7 p.G215S as potential protective factor for Alzheimer's disease.
    Sassi C; Nalls MA; Ridge PG; Gibbs JR; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Clement N; Lord J; Turton J; Bras J; Almeida MR; ; Holstege H; Louwersheimer E; van der Flier WM; Scheltens P; Van Swieten JC; Santana I; Oliveira C; Morgan K; Powell JF; Kauwe JS; Cruchaga C; Goate AM; Singleton AB; Guerreiro R; Hardy J
    Neurobiol Aging; 2016 Oct; 46():235.e1-9. PubMed ID: 27289440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.
    Nho K; Kim S; Horgusluoglu E; Risacher SL; Shen L; Kim D; Lee S; Foroud T; Shaw LM; Trojanowski JQ; Aisen PS; Petersen RC; Jack CR; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2017 May; 10(Suppl 1):29. PubMed ID: 28589856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic risk of Alzheimer's disease beyond APOE ε4: systematic review of Alzheimer's genetic risk scores.
    Stocker H; Möllers T; Perna L; Brenner H
    Transl Psychiatry; 2018 Aug; 8(1):166. PubMed ID: 30143603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in APOE cluster region and Alzheimer's disease risk.
    Cervantes S; Samaranch L; Vidal-Taboada JM; Lamet I; Bullido MJ; Frank-García A; Coria F; Lleó A; Clarimón J; Lorenzo E; Alonso E; Sánchez-Juan P; Rodríguez-Rodríguez E; Combarros O; Rosich M; Vilella E; Pastor P
    Neurobiol Aging; 2011 Nov; 32(11):2107.e7-17. PubMed ID: 21752496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.